HOME     |     CONTACT


Search  

EastGen News

SEMEX ANNOUNCES JON SCHEFERS NAMED US GENERAL MANAGER
Semex Is Pleased To Announce The Appointment of Jon Schefers as the US General Manager, Effectiv...
NEOGEN® AND SEMEX® PARTNER TO DELIVER SEMEX’S IMMUNITY TECHNOLOGY FOR HEALTHIER HERDS
Neogen Corporation and Semex announced today their partnership to deliver Semex’s Immunity Te...
SEMEX ANNOUNCES RYAN LETT SUCCEEDS DAVID MAYO AT SEMEX NEW ZEALAND
Semex is pleased to announce that Ryan Lett will succeed David Mayo as General Manager of Semex N...
BOVITEQ ANNOUNCES NEW LAB & SATELLITE AT ARIZONA DAIRY COMPANY
Boviteq is thrilled to announce opening a cutting-edge OPU (Oocyte Pick-Up) satellite facility and ...
SEMEX 2025-2026 BOARD OF DIRECTORS ANNOUNCED
Semex is pleased to announce its 2025-2026 Board of Directors. Jean-François Morin (CIAQ) wi...
BOVITEQ ANNOUNCES NEW LICENSEE IN JAPAN
Boviteq is pleased to announce that Nosawa, a longstanding partner of Semex for over 40 years, will...

View All Articles
Semex's Elevate Female Immunity Test Wins World Ag Expo Top-10 New Products Competition
Article posted on December 19, 2018, 12:09:21

The Top-10 New Product Award Competition is conducted annually by the International Agri-Center®, in conjunction with World Ag Expo® (WAE). Nominations are submitted by WAE exhibitors and judged by farmers, ranchers and industry professionals. This year, Semex’s Elevate™ Female Immunity Test is one of the Top-10 winners and will be recognized at the show held February 12-14 in Tulare, California!



Launched on December 4, 2012, Immunity+ was billed as an industry first – an exclusive product that would dramatically change the way dairymen developed their own breeding strategies and managed herd health. With Elevate, its female genomic testing program, Semex offers a genomic test that ranks and selects cows for both their Immunity+ genomic results and their genetic merit!



With Elevate and the Immunity+ genomic test, there’s no more guess work as to which cows will better resist disease. Armed with both genomic information and Immunity+ results, producers are able to make faster genetic progress towards a stronger, more disease resistant herd, reducing losses and drug use. Immunity+ heritability is 30%, similar to that of milk production. Semex is excited to be the only AI company to deliver uncompromised herd health gains that can be made by identifying both female immune response and utilizing Immunity+ sires.



"With Elevate and its Immunity+ genomic test, producers no longer have to guess which cows are their healthiest," says Gordon Miller, Semex Sr. Vice President, Sales & Business Development. "Instead, they're able to tailor their breeding program with both genomic information as well as Immunity+ results categorized as high, average or low health. They make faster genetic progress towards a stronger, more disease resistant herd, reducing losses and drug use. Immunity+ heritability is 30%, similar to that of milk production. We're excited for herd health gains that can be made by both identifying female health and utilizing Immunity+ sires!"



"Elevate is the only program that makes genomic testing completely seamless," explains Paul Krueger VP, Global Key Account & Solutions Strategy. "Our app collects and identifies the genomic samples and minimizes labor and time invested. There's no paperwork involved and no hair to pull. The information is automated between the app, the Elevate test, SemexWorks™ and OptiMate™, our sire selection and mating programs. All our clients need to do is take an ear tissue sample and ship it to the lab. The rest of the process is seamless."



Miller adds that Elevate and the Immunity+ test is yet another example of Semex delivering practical solutions to farmers, widening the gap between those simply selling genetics, and those offering the technological advancements needed on today's farms.




Print this Article | Email this Article